288 related articles for article (PubMed ID: 29556944)
41. Ductal carcinoma in situ with distorting sclerosis on core biopsy may be predictive of upstaging on excision.
Walters LL; Pang JC; Zhao L; Jorns JM
Histopathology; 2015 Mar; 66(4):577-86. PubMed ID: 25231210
[TBL] [Abstract][Full Text] [Related]
42. Breast-specific gamma imaging: correlations with mammographic and clinicopathologic characteristics of breast cancer.
Park JY; Yi SY; Park HJ; Kim MS; Kwon HJ; Park NH; Moon SY
AJR Am J Roentgenol; 2014 Jul; 203(1):223-8. PubMed ID: 24951219
[TBL] [Abstract][Full Text] [Related]
43. Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study.
Tanaka K; Masuda N; Hayashi N; Sagara Y; Hara F; Kadoya T; Matsui A; Miyazaki C; Shien T; Tokunaga E; Hayashi T; Niikura N; Maeda S; Komoike Y; Bando H; Kanbayashi C; Iwata H
Breast Cancer; 2021 Jul; 28(4):896-903. PubMed ID: 33599914
[TBL] [Abstract][Full Text] [Related]
44. Application of magnetic resonance computer-aided diagnosis for preoperatively determining invasive disease in ultrasonography-guided core needle biopsy-proven ductal carcinoma in situ.
Ahn HS; Kim SM; Kim MS; Jang M; Yun B; Kang E; Kim EK; Park SY; Kim B
Medicine (Baltimore); 2020 Jul; 99(31):e21257. PubMed ID: 32756104
[TBL] [Abstract][Full Text] [Related]
45. Role of FDG-PET/CT in prediction of underestimation of invasive breast cancer in cases of ductal carcinoma in situ diagnosed at needle biopsy.
Shigematsu H; Kadoya T; Masumoto N; Matsuura K; Emi A; Kajitani K; Amioka A; Okada M
Clin Breast Cancer; 2014 Oct; 14(5):358-64. PubMed ID: 24962555
[TBL] [Abstract][Full Text] [Related]
46. Predicting Upstaging of DCIS to Invasive Disease: Radiologists's Predictive Performance.
Selvakumaran V; Hou R; Baker JA; Yoon SC; Ghate SV; Walsh R; Litton TP; Lu LX; Devalapalli A; Kim C; Soo MS; Hwang ES; Lo JY; Grimm LJ
Acad Radiol; 2020 Nov; 27(11):1580-1585. PubMed ID: 32001164
[TBL] [Abstract][Full Text] [Related]
47. Breast ductal carcinoma in situ with micro-invasion versus ductal carcinoma in situ: a comparative analysis of clinicopathological and mammographic findings.
Zhang M; Lin Q; Su XH; Cui CX; Bian TT; Wang CQ; Zhao J; Li LL; Ma JZ; Huang JL
Clin Radiol; 2021 Oct; 76(10):787.e1-787.e7. PubMed ID: 34052010
[TBL] [Abstract][Full Text] [Related]
48. Invasive lobular carcinoma: detection with mammography, sonography, MRI, and breast-specific gamma imaging.
Brem RF; Ioffe M; Rapelyea JA; Yost KG; Weigert JM; Bertrand ML; Stern LH
AJR Am J Roentgenol; 2009 Feb; 192(2):379-83. PubMed ID: 19155397
[TBL] [Abstract][Full Text] [Related]
49. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
[TBL] [Abstract][Full Text] [Related]
50. Breast-specific gamma imaging with Tc-99m-sestamibi in the diagnosis of breast cancer and its semiquantitative index correlation with tumor biologic markers, subtypes, and clinicopathologic characteristics.
Tan H; Zhang H; Yang W; Fu Y; Gu Y; Du M; Cheng D; Shi H
Nucl Med Commun; 2016 Aug; 37(8):792-9. PubMed ID: 27058361
[TBL] [Abstract][Full Text] [Related]
51. Scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia at ultrasound-guided core needle biopsy.
Ko E; Han W; Lee JW; Cho J; Kim EK; Jung SY; Kang MJ; Moon WK; Park IA; Kim SW; Kim KS; Lee ES; Min KH; Kim SW; Noh DY
Breast Cancer Res Treat; 2008 Nov; 112(1):189-95. PubMed ID: 18060577
[TBL] [Abstract][Full Text] [Related]
52. A mass on breast imaging predicts coexisting invasive carcinoma in patients with a core biopsy diagnosis of ductal carcinoma in situ.
King TA; Farr GH; Cederbom GJ; Smetherman DH; Bolton JS; Stolier AJ; Fuhrman GM
Am Surg; 2001 Sep; 67(9):907-12. PubMed ID: 11565774
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic accuracy of core biopsy for ductal carcinoma in situ and its implications for surgical practice.
Dillon MF; Quinn CM; McDermott EW; O'Doherty A; O'Higgins N; Hill AD
J Clin Pathol; 2006 Jul; 59(7):740-3. PubMed ID: 16803949
[TBL] [Abstract][Full Text] [Related]
54. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
55. Ductal carcinoma in situ diagnosed by breast needle biopsy: Predictors of invasion in the excision specimen.
Doebar SC; de Monyé C; Stoop H; Rothbarth J; Willemsen SP; van Deurzen CH
Breast; 2016 Jun; 27():15-21. PubMed ID: 27212695
[TBL] [Abstract][Full Text] [Related]
56. Predicting invasion in mammographically detected microcalcification.
Bagnall MJ; Evans AJ; Wilson AR; Pinder SE; Denley H; Geraghty JG; Ellis IO
Clin Radiol; 2001 Oct; 56(10):828-32. PubMed ID: 11895299
[TBL] [Abstract][Full Text] [Related]
57. Usefulness of breast-specific gamma imaging as an adjunct modality in breast cancer patients with dense breast: a comparative study with MRI.
Kim BS
Ann Nucl Med; 2012 Feb; 26(2):131-7. PubMed ID: 22006539
[TBL] [Abstract][Full Text] [Related]
58. Predictive factors for the presence of invasive components in patients diagnosed with ductal carcinoma in situ based on preoperative biopsy.
Lee KH; Han JW; Kim EY; Yun JS; Park YL; Park CH
BMC Cancer; 2019 Dec; 19(1):1201. PubMed ID: 31822268
[TBL] [Abstract][Full Text] [Related]
59. Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features?
Shi B; Grimm LJ; Mazurowski MA; Baker JA; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
Acad Radiol; 2017 Sep; 24(9):1139-1147. PubMed ID: 28506510
[TBL] [Abstract][Full Text] [Related]
60. Prognostic value of primary tumor SUV
Yoo J; Yoon HJ; Kim BS
Ann Nucl Med; 2017 Jan; 31(1):19-28. PubMed ID: 27645144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
